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1. Introduction  
Sixty percent of patients with colorectal cancer (CRC) are afflicted with distant metastases 
(liver or lung metastatic process) or a local relapse of malignancy (Bird et al., 2006). The 
possibilities of surgical and oncological treatment of this disease offer us a large spectrum of 
treatments including the combination of surgical procedures and consecutive oncological 
treatments. In the case of radical surgical therapy we can consider the curative access. The 
main medical problem of CRC is the high rate of recurrences after radically performed 
surgical therapy. The operability of recurrence is only about 30% in the case of local relapse 
and 20% in the case of distant metastases (Coleman et al., 2008; Kobayashi et al., 2007). The 
second dominant problem is the early recurrence of CRC after radical surgical treatment, 
when the patients undergo a difficult and exhausting procedure with a high risk of 
perioperative complications without any significant differences in overall survival against 
modern palliative therapy (Van den Eynde & Hendlisz, 2009).  
Contemporary clinical and histopathological prognostic factors (staging, grading, etc.) used 
for the detection of patients with a high risk of relapse and a short overall survival rate and 
for the indication of adjuvant oncological treatment after radical surgery are not sufficient. 
Tumor infiltrating lymphocytes (TIL) were described as a good prognostic factor for patients 
with a high risk of relapse. They are critical indicators of efficient antitumor immunological 
response. Their number, type and morphology of TIL cells determine resulting tumor 
prognosis (Atreya & Neurath, 2008; Galon et al., 2006). They could be connected also with 
the suppression of micrometastatical disease after radical surgery (Gajewski et al., 2006; 
Pages et al., 2005). We can recognize either the type of immune cells or distinguish their 
morphological aspects (infiltration of any part of tumor or surrounding of tumor or 
tributary lymph nodes) (Talmadge et al., 2007).  
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We detail only short overview of their types and function. We recommend the readers with 
deeper interest in these problems to find comprehensive reviews in the cited papers 
(Jochems et al., 2011; Ohtani 2007). From this view we find CD8+ and CD4+ T lymphocytes 
(Fig. 1a & Fig. 1b), natural killer cells (Fig. 1c), dendritic cells (Fig. 1d), macrophages, etc. 
The exact function of these cells is under current discussion. We only know that they play 
main role in controlling tumor development and growth. CD8+ T lymphocytes within 
cancer cell nests of colorectal cancer have significant impact on the survival of patients. They 
contain the cytolytic enzyme granzyme-B. In case of increased proliferating activity of CD8+ 
T lymphocytes we observe their activated and cytotoxic phenotype that is significantly 
associated with the absence of early metastatic events (vascular emboli, lymphatic invasion 
or perineural invasion of tumor cells) and with a decreased rate of cancer recurrence (Atreya 
& Neurath, 2008, Pages et al., 2010). A high density of memory T lymphocytes within 
colorectal cancer tissue was more frequently observed in patients without early detectable 
signs of metastatic events and was associated with both improved disease free interval (DFI) 
and prolonged overall survival (OS) (Galon et al., 2006; Pages et al., 2005).  
Natural killer cells (NK cells) mediate an effective lysis of cancer cells but the mechanism of 
detection of cancer cells is different from CD8+ T lymphocytes (Cooper et al., 2009). NK cells 
are mainly involved in the innate immune response and do not recognize specific tumor 
associated antigen on the surface of cancer cells as CD8+ T lymphocytes. NK cells lyse the 
cancer cells that are opsonized by surface antibody. NK cells also respond to other signals as 
cytokines produced by antigen presenting cells, which allow them to mediate early host 
responses against pathogen (Moretta et al., 2006). Decreased preoperative number of NK 
cells was associated with increased frequency of postoperative recurrence of colorectal 
cancer (Atreya & Neurath, 2008; Cooper et al., 2001). Their crucial role in the elimination of 
haematological malignancies, primary and secondary tumors has been recognized (Lucas et 
al., 2007; Ljunggren & Malmberg, 2007, Stojanovic & Cerwenka, 2011).  In the last year there 
are some signs that NK-cells have the capacity for memory-like responses, a property that 
was previously thought to be limited to adaptive immunity, but in this view the discussion 
still continues (Cooper et al., 2009).  
Dendritic cells are considered to be most potent antigen presenting cells. They play key role 
in activation, stimulation and recruitment of T lymphocytes. They can also induce antigen-
specific unresponsiveness or immune tolerance. Immature dendritic cells enter tumor tissue, 
uptake and process its antigens. Then after they migrate to lymph nodes, undergo 
maturation and interact with T-lymphocytes that are able to recognize presented antigen 
and so T-lymphocytes play effector role of this tumor-specific immunity (Atreya & Neurath, 
2008; Pages et al., 2005; Sandel et al., 2005; Steinman et al., 2003).  
Macrophages are important producers of different factors that have function during tumor 
progression and also during tumor progression control. Their function is not fully 
understand, but it was described that the number of tumor infiltrating macrophages 
correlates with overall survival of colorectal cancer patients (Atreya & Neurath, 2008; 
Pollard, 2004; Forssell et al., 2007). It seems that several types of tumor infiltrating 
macrophages influence the balance between pro- and anti-tumor properties of immune 
system (Forssell et al., 2007).  
From the morphologic view we can observe TIL in the specific portions of tumor and so we 
detect lymphocytic infiltration intratumoral (ITL – intratumoral lymphocytes) (Fig. 
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2a),intrastromal (ISL – intrastromal lymphocytes) (Fig. 2b), peritumoral (PTL – peritumoral 
lymphocytes) (Fig. 2c) and Crohn-like reaction (Crohn-like PTL)(Fig. 2d). We can also 
describe reactive histological changes in tributary lymph nodes (LN reactions). It means 
follicular hyperplasia (LN-FH) (Fig. 3a.), sinus histiocytosis (LN-SH) (Fig. 3b.) and the 
presence of granulomas (LN-GR) (Fig. 3c) (Ogino et al, 2009; Pages et al., 2005). 
The aim of this study was to analyze the relationship of contemporary clinical and 
histopathological factors and TIL to determine patients with a high risk of poor overall 
survival and tendency to early recurrence of malignancy with shortened disease free 















Fig. 1. Examples of tumor infiltration by immune cells: a) CD8+ T lymphocytes; b) CD4+ T 










Fig. 2. Different localisation of TIL within the tumor tissue: a) intratumoral lymphocytes;  
b) intrastromal lymphocytes; c) peritumoral lymphocytes and d) Crohn-like peritumoral 




Fig. 3. Reactive histological changes in tributary lymph nodes: a) follicular hyperplasia; b) sinus 
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We analyzed 150 patients who underwent radical surgical procedure for CRC between the 
years 2004-2007 at the Department of Surgery, Medical School and Teaching Hospital in 
Pilsen, Charles University in Prague. We selected only patients who were operated on 
electively – our aim was to decrease the risk of inflammation that is often connected with the 
acute operation of CRC and does not depend on the immune reaction against a tumor but 
could be evoked by the distension of the bowel. We also excluded patients who had risk of 
understaging (for example low number of analysed lymph nodes) and patients with a 
synchronous metastatic process. The inclusion standard was also the entire follow-up of 
patients during the whole postoperative period to increase the number of patients with a 
diagnosed early recurrence of CRC. 
The following clinical parameters were statistically analysed in relation to the disease free 
interval (DFI) and the overall survival (OS): staging, grading, preoperative leukocytosis, 
type of surgical procedure (radical vs. palliative), postoperative complications and 
postoperative oncological treatment.  
2.1 Histology 
We examined three different sections of each tumor and also sections of all found lymph 
nodes. Tissue for light microscopy was fixed in 4% formaldehyde and embedded in paraffin 
using routine procedures. Five micrometer-thick sections were cut from the tissue blocks 
and stained with hematoxylin-eosin. 
The type and grade of all tumors were determined according to WHO 2000 guidelines. The 
stage of tumors was established according to UICC 2002 guidelines. We evaluated 
endovascular (VI), endolymphatic (LI) and perineural infiltration (PI) by cancer cells (0 – 
none, 1 – yes). Lymphocytic infiltration was detected as intratumoral (ITL – intratumoral 
lymphocytes), intrastromal (ISL – intrastromal lymphocytes), peritumoral (PTL – 
peritumoral lymphocytes) and Crohn-like reaction (Crohn-like PTL), and scaled as none (0), 
mild (1), moderate (2) and severe (3). Reactive histological changes in lymph nodes (LN 
reactions) were detected as follicular hyperplasia (LN-FH), sinus histiocytosis (LN-SH) and 
the presence of granulomas (LN-GR), and all these parameters were quantified in the same 
manner as lymphocytic infiltration. 
2.2 Immunohistochemistry  
For immunohistochemical investigations the following primary antibodies were used: CD4 
(clone 4B12, 1:50, Vector Laboratories, Burlingame, CA, USA) and CD8 (clone C8/144B, 1:50, 
Dako, Glostrup, Denmark). Microwave pretreatment was used in both cases. The primary 
antibodies were visualized using the supersensitive streptavidin-biotin-peroxidase complex 
(Biogenex, San Ramon, CA). Appropriate positive and negative control slides were employed. 
The density of intratumoral infiltration by lymphocytes was evaluated in five High power 
microscopical fields (HPF) and expressed as the number of immunopositive cells per HPF. 
2.3 Statistical evaluation   
Statistical analysis was processed by the statistical software Statistica 9.0. The mean, median, 
standard deviation (SD), minimum, maximum, quartiles, frequencies and other basic 
statistical measurements were computed in given groups and subgroups of patients 
corresponding to studied clinical and histopathological parameters.  
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The relationships between the variables were described by Spearman rank correlation 
coefficients.  
The analyses of Overall survival (OS) and Disease free interval (DFI) were performed by 
Kaplan-Meier´s survival functions. The influence of given covariates (clinical and 
histopathological factors) was tested by the Log-Rank test and Wilcoxon test. The Cox 
regression hazard model, hazard ratio (HR) and 95% confidence interval (CI) for HR were 
computed for the evaluation of given clinical and histopathological factors to OS or DFI. 
Multivariate analysis was performed by the use of classification and regression trees 
(CART). The Cox regression hazard model (stepwise regression) was applied to find the 
predictors in CART. 
3. Results 
The statistical analysis of the studied cohort of patients after surgical treatment for colorectal 
cancer demonstrated an acceptable distribution of basic statistical description parameters 
(gender ratio 93:57 (male vs. female)). 1, 3 and 5 years overall survival was 92.2%, 76.5% and 
70.2% and 1, 3 and 5 year DFI was 85.3%, 64.3% and 49.4%.  
The Spearman rank correlation coefficient did not prove any stronger correlation than a 
moderate correlation at endolymphatic invasion (LI) and lymph node infiltration by 
metastatic process (Spearman rank correlation coefficient 0.56, p<0,05). All the other studied 
factors were independent factors or factors with a low correlation. 
Statistical analysis proved lymph node infiltration by metastatic process as statistically 
significant for the prognosis of overall survival (p<0.05) and N2 status of lymph nodes 
increased the risk of shorter overall survival 9.3x (Fig. 4.). 
 
 
Fig. 4. Statistical analysis proved the lymph node infiltration by a metastatic process as 
statistically significant for the prognosis of overall survival (p<0.05), and the N2 status of 
lymph nodes increased the risk of a shorter overall survival 9.3x. 
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Endovascular infiltration (VI) was proved as a negative prognostic factor of shorter overall 
survival (Fig.5.). Patients with positive histopathological findings of VI have 3.1x increased 
risk for shorter overall survival. The presence of peritumoral lymphocytes (PTL) (Fig.6.) and 
of Crohn-like PTL (Fig.7.) was proved as a positive prognostic factor of OS. Patients with a 
positive histopathological finding of PTL and Crohn-like PTL have a decreased risk for 
shorter overall survival (2.3x and 2.3x respectively). Lymph node follicular hyperplasia (LN-
FH) was verified as a positive prognostic factor for longer overall survival (Fig.8.). The 
statistical significance of LN-FH increased also with the raised density of infiltration.  LN-
FH positivity decreased the risk of shorter overall survival 3.3times. 
The severity of CD8+ lymphocytic infiltration was proved by the Cox regression hazard 
model as a positive prognostic factor enlarging overall survival (cut off 30 cells/HPF). The 
severity of CD4+ lymphocytic infiltration was proved as a significant factor for the 
prognosis of overall survival (cut off 4cells/HPF) with 2.5x increased hazard ratio in 
patients over the cut off (Fig.9.). Statistical analysis did not confirm the statistical 











Fig. 5. Endovascular infiltration by cancer cells (VI) was proved as a statistically significant 
factor for the prognosis of overall survival (p<0.05). The patients with a positive 
histopathological finding of VI have 3.1x higher risk ratio for shorter overall survival. 
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Fig. 6. Presence of peritumoral lymphocytes (PTL) was proved as a statistically significant 
positive factor for the prognosis of overall survival (p<0.05). The patients with a positive 
histopathological finding of PTL have 2.3x lower risk ratio for a shorter overall survival. 
 
 
Fig. 7. Presence of Crohn-like PTL was proved as a statistically significant positive factor for 
the prognosis of overall survival (p<0.05). The patients with a positive histopathological 
finding of PTL have 2.3x lower risk ratio for a shorter overall survival. 
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Fig. 8. Lymph node follicular hyperplasia (LN-FH) was verified as a positive prognostic 
factor for a longer overall survival (p<0.05). The statistical significance of LN-FH increased 
also with the raised density of infiltration. LN-FH positivity decreased the risk of a shorter 
overall survival 3.3x. 
 
 
Fig. 9.  Severity of CD4+ lymphocytic intratumoral infiltration was proved as a significant 
factor for the prognosis of overall survival (cut off 4cells/HPF) with a 2.5x increased hazard 
ratio in patients over the cut off (p<0.05).  
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The Multivariate Cox Regression Hazard Model proved the combination of the severity of 
lymph node infiltration by metastatic process and LN-FH as the best prognostic factors for 
the prediction of the risk of shorter overall survival. This situation is demonstrated in the 
Classification and Regression Tree (CART)(p<0.05) (Fig.10.). All other studied parameters 





Fig. 10. Multivariate Cox Regression Hazard Model proved the combination of the severity 
of lymph node infiltration by a metastatic process and LN-FH as the best prognostic factors 
for the prediction of risk of a shorter overall survival (p<0.05). This situation is 
demonstrated in the Classification and Regression Tree (CART).  
Perineural infiltration (PI) was proved as a negative prognostic factor of an earlier 
recurrence (Fig.11.). Patients with a positive histopathological finding of PI have 3.8x 
increased risk for shorter DFI. 
The severity of CD8+ lymphocytic infiltration was proved by the Cox regression hazard 
model as a positive prognostic factor enlarging DFI (cut off 30cells/HPF) (Fig.12.). Patients 
over the cut off have 2.2x increased risk of an early recurrence. The severity of CD4+ 
lymphocytic infiltration was not proved as a significant factor for the prognosis of DFI. 
Statistical analysis did not confirm the statistical significance of the CD8/CD4 ratio. 
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Fig. 11. Perineural infiltration (PI) was proved as a negative prognostic factor of an earlier 
recurrence (p<0.05). Patients with a positive histopathological finding of PI have a 3.8x 
increased risk for shorter DFI. 
Statistical analysis proved lymph node infiltration by a metastatic process as statistically 
significant for the prognosis of DFI and N2 status of lymph nodes increased the risk of 
shorter DFI 5x (Fig. 13.). 
 
 
Fig. 12.  Severity of CD8+ lymphocytic intratumoral infiltration was proved as a positive 
prognostic factor enlarging DFI (cut off 30 cells/HPF) by the Cox regression hazard model 
(p<0.05). Patients over the cut off have a 2.2x increased risk of an early recurrence. 
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Fig. 13. Statistical analysis proved lymph node infiltration by a metastatic process as 
statistically significant for the prognosis of DFI, and a N2 status of lymph nodes 5x 
increased the risk of a shorter DFI (p<0.05).  
The Multivariate Cox Regression Hazard Model proved the combination of the severity of 
the lymph node infiltration by a metastatic process and the severity of CD8 positivity of 
infiltrating lymphocytes as the best prognostic factors for the prediction of risk of early 
recurrence (p<0.05). This situation is demonstrated in the Classification and Regression Tree 
(CART) (Fig. 14). All other studied parameters were not proved as statistically significant for 
the prognosis of DFI. 
4. Discussion 
The role of the adaptive immunological response in controlling the growth and relapse of 
CRC remains controversial and contemporary studies have not answered all the questions 
about the prognosis of patients after radical surgical treatment of CRC (Galon et al., 2006; 
Ohtani, 2007; Van den Eynde & Hendlisz, 2009). We analysed our large cohort of patients of 
CRC with consideration to detect the negative and also positive prognostic factors of early 
recurrence of the disease and the poor overall survival after radical surgery. It was 
stimulated by the unsatisfactory situation and some dilemmas in the indication of surgical 
and oncological treatment, when early recurrence depreciates our effort to radical surgery 
with a high risk of complications and the long time of the decreased quality of life of our 
patients. 
In the presented clinico-pathological study we demonstrated that lymph node infiltration by 
a metastatic process, N2 status of lymph nodes, VI, and extent of CD4+ lymphocytic 
intratumoral infiltration as negative prognostic factors of OS. In contrary PTL, Crohn-like 
PTL, LN-FH, and severity of CD8+ lymphocytic intratumoral infiltration were proved as 
positive prognostic factors of the overall survival.  
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Fig. 14. Multivariate Cox Regression Hazard Model proved the combination of the severity 
of lymph node infiltration by a metastatic process and the severity of CD8 positivity as the 
best prognostic factors for the prediction of risk of an early recurrence (p<0.05). This 
situation is demonstrated in the Classification and Regression Tree (CART). 
The combination of the severity of the lymph node infiltration by a metastatic process and 
LN-FH were proved as the best prognostic factors for the prediction of risk of a shorter 
overall survival by the Multivariate Cox Regression Hazard Model.  
We also demonstrated PI, lymph node metastatic infiltration and the N2 status of lymph 
nodes as negative prognostic factors of an earlier recurrence, and the severity of CD8+ 
lymphocytic intratumoral infiltration as a positive prognostic factor enlarging DFI. The 
combination of the severity of the lymph node infiltration by a metastatic process and the 
severity of CD8+ lymphocytic intratumoral infiltration were proved as the best prognostic 
factors for the prediction of the risk of an early recurrence by the Multivariate Cox 
Regression Hazard Model.  
Our results support the hypothesis that the adaptive immunological response in tumor 
tissue and its reaction in regional lymph nodes can influence the behavior of CRC and so 
affect the prognosis of patients (Atreya & Neurath, 2008; Galon et al., 2006). CD4 and CD8 
positivity of ITL was demonstrated as a key histopathological sign of tumor-specific 
immune response that could reflect the contemporary clinical situation and a tendency to 
relapse (CD4+) or the larger overall survival (CD8+) (Chiba et al. 2004; Koch et al., 2006, 
Pages et al., 2010).  
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We assessed several types of tumor infiltrating lymphocytes and clearly identified their 
relationships to relapse and the overall survival as positive or negative prognostic factors in 
contrary to previous publications that evaluated only the infiltration of the tumor but not 
the quality and type of infiltration (Ogino et al., 2009).  
Tumor infiltration by lymphocytes seems to be a promising prognostic factor reflecting the 
risk of patients to early recurrence or poor overall survival. Future work has to be focused 
on the molecular-biological background of tumor infiltration by lymphocytes to understand 
their pathophysiological functions (Pages et al., 2005, Zbar, 2004).   
5. Conclusion 
Tumor infiltrating lymphocytes seem to be promising prognostic factors that could find 
their use in colorectal surgery and consecutive oncological treatment as an indicator of the 
type or combinations of therapies reflecting the risk of patients to early recurrence or poor 
overall survival. The TIL status corresponds to immune control of cancer progression.  
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